Antibiotice SA 2021 Integrated Annual Report

The report presents Antibiotice's financial and non-financial performance in 2021. The company achieved a 13% increase in profit compared to the previous year, driven by its international business, which accounted for 39% of the total revenue. The report highlights Antibiotice's commitment to sustainability, including its efforts in consolidating its business, investing in research and development, and maintaining its position as a world leader in the production of Nystatin. The report also highlights Antibiotice's social responsibility efforts, including its support of the Romanian health system during the COVID-19 pandemic and its various community investment initiatives.